Tropomyosin-related kinase inhibitors
US9328096B2 · kind B2 · utility
1Cited by
24References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 2015 |
| Grant date | May 3, 2016 |
| Priority date | — |
| Expiry date | May 6, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula Iand their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine, in particular as TrkA antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.